Law360, New York (May 07, 2010, 6:03 PM ET) -- GE Healthcare Bioscience BioProcess Corp. has agreed to pay $126,000 to resolve allegations that it exported and re-exported bioreactor kits to China, Mexico and elsewhere without obtaining the proper licenses from the U.S. Department of Commerce.
The alleged violations were committed by Wave Biotech LLC, a company acquired by GE Healthcare in April 2007, according to a settlement agreement posted on Commerce's Bureau of Industry and Security Web site Friday.
Wave unlawfully exported the bioreactor kits from the U.S. to Mexico, Singapore, Taiwan, India and China...
GE Healthcare To Pay Up For Export Violations
To view the full article, take a free trial now.
